Package | us.nlm.vsac |
Resource Type | ValueSet |
Id | 2.16.840.1.113762.1.4.1047.543 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1047.543/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.543 |
Version | 20240620 |
Status | active |
Date | 2024-06-20T01:22:57-04:00 |
Name | BevacizumabInjection |
Title | Bevacizumab injection |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: This value set includes concepts related to bevacizumab injections.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes relevant concepts associated with bevacizumab injections.),(Exclusion Criteria: No exclusions.) |
No resources found
CodeSystem | |
rxnorm | RxNorm |
No narrative content found in resource
{ "resourceType": "ValueSet", "id": "2.16.840.1.113762.1.4.1047.543", "meta": { "versionId": "14", "lastUpdated": "2024-06-20T01:22:57.000-04:00", "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ] }, "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/valueset-author", "valueContactDetail": { "name": "ASRS Quality Measure Development Author" } }, { "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate", "valueDate": "2024-06-20" }, { "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate", "valueDate": "2024-06-20" } ], "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.543", "identifier": [ { "system": "urn:ietf:rfc:3986", "value": "urn:oid:2.16.840.1.113762.1.4.1047.543" } ], "version": "20240620", "name": "BevacizumabInjection", "title": "Bevacizumab injection", "status": "active", "date": "2024-06-20T01:22:57-04:00", "publisher": "ASRS Quality Measure Development Steward", "jurisdiction": [ { "coding": [ { "system": "urn:iso:std:iso:3166", "code": "US" } ] } ], "purpose": "(Clinical Focus: This value set includes concepts related to bevacizumab injections.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes relevant concepts associated with bevacizumab injections.),(Exclusion Criteria: No exclusions.)", "compose": { "include": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "concept": [ { "code": "1657066", "display": "4 ML bevacizumab 25 MG/ML Injection" }, { "code": "1657073", "display": "16 ML bevacizumab 25 MG/ML Injection" }, { "code": "2046140", "display": "16 ML bevacizumab-awwb 25 MG/ML Injection" }, { "code": "2046148", "display": "4 ML bevacizumab-awwb 25 MG/ML Injection" } ] } ] }, "expansion": { "identifier": "urn:uuid:bb1a1b8a-6e12-43b1-8b44-15e85be33219", "timestamp": "2025-05-23T17:34:50-04:00", "total": 4, "contains": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1657066", "display": "4 ML bevacizumab 25 MG/ML Injection" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1657073", "display": "16 ML bevacizumab 25 MG/ML Injection" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "2046140", "display": "16 ML bevacizumab-awwb 25 MG/ML Injection" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "2046148", "display": "4 ML bevacizumab-awwb 25 MG/ML Injection" } ] } }